Outcome | Group | Baseline | 5 weeks | 13 weeks | ||||
---|---|---|---|---|---|---|---|---|
 |  | Mean (SD) | Mean (SD) | P a | LSMD (95 % CI)a | Mean (SD) | P a | LSMD (95 % CI)a |
FSS | A | 4.70 (1.22) | 3.38 (1.10) | 0.017 | −0.45 (−0.84, −0.07) | 3.34 (1.17) | 0.074 | −0.36 (−0.75, 0.03) |
B | 4.74 (1.09) | 3.58 (1.12) | 0.090 | −0.33 (−0.71, 0.04) | 3.51 (1.19) | 0.230 | −0.26 (−0.64, 0.12) | |
C | 4.52 (1.26) | 4.47 (1.18) | - | - | 4.24 (1.22) | - | - | |
SRI-short form | A | 62.59 (17.77) | 42.21 (14.18) | 0.039 | −5.92 (−11.58, −0.27) | 42.28 (14.33) | 0.063 | −5.69 (−11.64, 0.26) |
B | 55.50 (14.23) | 42.10 (13.66) | <0.001 | −9.22 (−14.69, −3.76) | 39.81 (13.55) | <0.001 | −10.34 (−16.10, −4.58) | |
C | 59.26 (18.34) | 56.47 (18.03) | - | - | 56.67 (20.11) | - | - | |
BDI | A | 16.59 (8.60) | 9.02 (6.92) | 0.338 | −1.39 (−3.82, 1.04) | 9.64 (6.39) | 0.386 | −1.35 (−3.88, 1.18) |
B | 15.12 (7.67) | 8.88 (7.66) | 0.086 | −2.14 (−4.54, 0.25) | 7.89 (7.15) | 0.018 | −2.92 (−5.41, −0.43) | |
C | 14.91 (6.78) | 13.36 (6.39) | - | - | 14.00 (8.42) | - | - | |
NRS | A | 6.57 (1.42) | 4.42 (1.98) | <0.001 | −1.01 (−1.54, −0.48) | 4.77 (2.22) | 0.006 | −0.76 (−1.33, −0.20) |
B | 6.53 (1.28) | 4.52 (1.70) | <0.001 | −0.98 (−1.50, −0.46) | 4.51 (1.95) | <0.001 | −0.90 (−1.46, −0.34) | |
C | 6.47 (1.38) | 6.53 (1.36) | - | - | 6.38 (1.69) | - | - | |
EQ-5D | A | 0.84 (0.10) | 0.91 (0.11) | 0.948 | 0.00 (−0.04, 0.03) | 0.92 (0.11) | 0.785 | 0.01 (−0.03, 0.05) |
B | 0.87 (0.10) | 0.91 (0.09) | 0.494 | 0.01 (−0.02, 0.05) | 0.94 (0.08) | 0.067 | 0.03 (0.00, 0.07) | |
C | 0.88 (0.11) | 0.88 (0.10) | - | - | 0.87 (0.15) | - | - |